The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3–E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression.
Abstract
The mouse MC3T3-E1 cell line is nontumorigenic and undergoes a typical program of osteoblast differentiation in vitro, producing a bone-like mineralized extracellular matrix. We report responses of these cells to dexamethasone (Dex) and 1,25-(OH)2D3 that are in contrast to findings from other osteoblast culture systems. First, chronic exposure of both early- and late-passaged MC3T3-E1 cells to 10(-7) M Dex, initiated during the proliferation period, blocked osteoblast differentiation, in contrast to the enhanced differentiation observed in cultures of fetal rat calvarial-derived cells. Secondly, 1,25-(OH)2D3 did not up-regulate expression (messenger RNA or protein synthesis) of the endogenous mouse osteocalcin (OC) gene. Several lines of evidence are presented that suggest this response is caused by sequence specific properties of the mouse OC vitamin D response element. We also observed both qualitative and quantitative differences in expression of cell growth (histone H2B) and phenotype-related genes (collagen, OC, osteopontin, glucocorticoid receptor, and 1, 25-(OH)2D3 receptor), between pre- and postmineralization stage osteoblasts, in response to 24 h steroid hormone treatment. Our findings in MC3T3-E1 cells are consistent with current concepts of selective influences of 1,25-(OH)2D3 and glucocorticoids as a function of osteoblast maturation. However, the inhibition of osteoblast differentiation by chronic Dex at 10(-7) M and the down-regulation of OC by 1,25-(OH)2D3 are novel observations relevant to species-specific responsiveness of mouse bone-expressed genes to steroid hormones during osteoblast differentiation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glucocorticoids can also inhibit osteoblast differentiation (249 -251), osteoblast attachment to bone matrix (252), and osteoblast production of IGF-I (253).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [250]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,460
Sudo, H., Kodama, H. A., Amagai, Y., Yamamoto, S., & Kasai, S. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.96.1.191 · Cited by 1,673
Owen, T. A., Aronow, M. S., Shalhoub, V., Barone, L. M., Wilming, L. G., Tassinari, M. S., Kennedy, M. B., Pockwinse, S. M., Lian, J. B., & Stein, G. S. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041430304 · Cited by 1,568
Self-citationCharacterization of cells with osteogenic potential from human marrow
Haynesworth, S. E., GOSHIMA, J., Goldberg, V., & Caplan, A. I. (1992) · Bone · doi:10.1016/8756-3282(92)90364-3 · Cited by 1,291
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
Lukert, B. P., & Raisz, L. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-352 · Cited by 1,063
Quarles, L. D., Yohay, D. A., Lever, L. W., Caton, R., & WENSTRUP, R. J. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070613 · Cited by 988
THE QUANTITATIVE HISTOCHEMISTRY OF BRAIN
Lowry, O. H., Roberts, N. R., Wu, M., Hixon, W. S., & Crawford, E. J. (1954) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71242-8 · Cited by 808
Cadherin-catenin complex: Protein interactions and their implications for cadherin function
Aberle, H., Schwartz, H. T., & Kemler, R. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960616)61:4 · Cited by 806
Genovese, C., Rowe, D. W., & Kream, B. E. (1984) · Biochemistry · doi:10.1021/bi00320a049 · Cited by 558
Research works printed but not linked: 4
- Frost, 1961, The effect of cortisone on lamellar osteoblastic activity., Henry Ford Hosp Med J, 9, 97
- Wyatt, 1996, Passage-dependent loss of osteoblast function but not proliferation markers in MC3T3–E1 cells, J Bone Miner Res, 11, S390
- Sztajnkrycer, 1994, Regulation of mouse bone Gla protein genes by glucocorticoids and 1,25-dihydroxyvitamin D3, J Bone Miner Res, 9, S288
- Zhang, 1996, Vitamin D3 inhibits the expression of the endogenous mouse osteocalcin genes in vivo, J Bone Miner Res, 11, S425
Cited by
Sorted by citations
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753
“inhibit differentiation in a murine osteoblastic cell line (34).”
BackgroundThe Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J., Thompson, P. D., Selznick, S. H., Dominguez, C. E., & Jurutka, P. W. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.325 · Cited by 1,428
“Avian PTH 2 GGGTCA GGA GGGTGT (244) Human PTH 2 GGTTCA AAG CAGACA (29, 39) Mouse osteocalcin 2 GGGCAA ATG AGGACA (162) Rat bone sialoprotein 2 AGGGTT TAT AGGTCA (245) PKA inhibitor 2 ATGTTG CTG AGGTCA (165) Rat PTHrP-proximal 2 AGGT A CTC AGTGAA (246) Rat PTHrP-distal 2 GGGTGG AGA GGGGTG (247)”
BackgroundKearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
In search of an osteoblast cell model for in vitro research
Czekanska, E. M., Stoddart, M. J., Richards, R. G., & Hayes, J. S. (2012) · European Cells and Materials · doi:10.22203/ecm.v024a01 · Cited by 570
In vitro differentiation of embryonic stem cells into mineralized osteoblasts
Nieden, N. I. Z., Kempka, G., & Ahr, H. J. (2003) · Differentiation · doi:10.1046/j.1432-0436.2003.700602.x · Cited by 347
Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention
Haussler, M. R., Haussler, C. A., Bartik, L., Whitfield, G. K., Hsieh, J., Slater, S. A., & Jurutka, P. W. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00093.x · Cited by 323
Franceschi, R. T. (1999) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411990100010201 · Cited by 274
Bikle, D. D. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-012-0098-z · Cited by 273
Molecular mechanisms of glucocorticoid-induced osteoporosis.
Patschan, D., Loddenkemper, K., & Buttgereit, F. (2001) · Bone · doi:10.1016/s8756-3282(01)00610-x · Cited by 201
Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts
Thomas, G. P., Baker, S., Eisman, J. A., & Gardiner, E. M. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1700451 · Cited by 184
“The increase in COL1 mRNA expression observed during the later stages of osteoblast differentiation is consistent with a number of other studies in differentiated mouse, but not rat, osteoblasts (Owen et al. 1991, Yamashita et al. 1996, Lian et al. 1997, Qu et al. 1998).”
MethodResultInfluential1,25-(OH)2-Vitamin D3 Suppresses the Bone-Related Runx2/Cbfa1 Gene Promoter
Drissi, H. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5474 · Cited by 173
Gardiner, E. M., Baldock, P. A. J., Thomas, G. P., Sims, N. A., Briffa, K., Hollis, B. W., White, C., Sunn, K. L., Morrison, N. A., Walsh, W. R., et al. (2000) · The FASEB Journal · doi:10.1096/fj.99-1075com · Cited by 169
Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture
Pereira, R. M. R., Delany, A. M., & CANALIS, E. M. (2001) · Bone · doi:10.1016/s8756-3282(01)00422-7 · Cited by 166
Smith, E., & Frenkel, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406294200 · Cited by 165
Self-citationCox, R. F., Hernández-Santana, A., Ramdass, S. K., McMahon, G. P., Harmey, J. H., & Morgan, M. P. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.583 · Cited by 161
Vitamin D and gene networks in human osteoblasts
van de Peppel, J., & van Leeuwen, J. P. T. M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00137 · Cited by 151
“1,25D3 stimulates BGLAP expression in human and rat osteoblasts while it inhibits BGLAP expression in murine osteoblasts (Lian et al., 1997; Zhang et al., 1997), supporting differences between human/rat osteoblasts and murine with respect to 1,25D3 responsiveness and mineralization.”
BackgroundGlucocorticoid-Induced Osteoporosis
Frenkel, B., White, W., & Tuckermann, J. P. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_8 · Cited by 154
Self-citationJaved, A., Gutiérrez, S., Montecino, M. A., van Wijnen, A. J., Stein, J. L., Stein, G. S., & Lian, J. B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7491 · Cited by 140
“Vitamin D does not mediate enhanced activity of the mouse OC promoter (70), and in fact, the mouse OC VDRE exhibits weak downregulation by the hormone (39).”
BackgroundSelf-citationHuang, W., Xie, Z., Konaka, H., Sodek, J., Zhau, H. E., & Chung, L. W. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3448 · Cited by 137
REGULATION OF BMP-INDUCED TRANSCRIPTION IN CULTURED HUMAN BONE MARROW STROMAL CELLS
Diefenderfer, D. L., Osyczka, A. M., Garino, J. P., & Leboy, P. S. (2003) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200300003-00005 · Cited by 121
Gene expression profiling of glucocorticoid-inhibited osteoblasts
Leclerc, N., Luppen, C., Ho, V., Nagpal, S., Hacia, J., Smith, E., & Frenkel, B. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0330175 · Cited by 115
“Inhibition of mineralized extracellular matrix formation by GCs was recapitulated in vitro using the MC3T3-E1 cell line and occurred only when GC treatment commenced prior to the seventh day of culture (Lian et al. 1997).”
BackgroundSelf-citationGlucocorticoids Inhibit Developmental Stage-specific Osteoblast Cell Cycle
Smith, E., Redman, R. A., Logg, C. R., Coetzee, G. A., Kasahara, N., & Frenkel, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001758200 · Cited by 113
Self-citationLuppen, C. A., Smith, E., Spevak, L., Boskey, A. L., & Frenkel, B. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.7.1186 · Cited by 108
“In this study, we used MC3T3-E1 cells, in which mineralized matrix formation is strongly inhibited by GC.(5,57) It should be noted that in MC3T3-E1 cells, like in rat calvarial osteoblasts,(58) GCs do not promote, but in fact inhibit, apoptosis (data not shown).”
MethodSelf-citationIgarashi, M., Kamiya, N., Hasegawa, M., Kasuya, T., Takahashi, T., & Takagi, M. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000020883.33256.fe · Cited by 108
“…et al. 1998, Ogston et al. 2002) and the present studies are presumably related to the effect of glucocorticoids, which depends on the degree of cellular differentiation and the donor species (Chen et al. 1983a,b, Lian et al. 1997) as well as the dose and duration of exposure (Jonsson et al. 1997).”
BackgroundResultInfluentialComposite PLA/PEG/nHA/Dexamethasone Scaffold Prepared by 3D Printing for Bone Regeneration
Li, X., Wang, Y., Wang, Z., Qi, Y., Li, L., Zhang, P., Chen, X., & Huang, Y. (2018) · Macromolecular Bioscience · doi:10.1002/mabi.201800068 · Cited by 101
Hurson, C. J., Butler, J. S., Keating, D., Murray, D. W., Sadlier, D. M., O’Byrne, J., & Doran, P. (2007) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-8-12 · Cited by 100
“They inhibit osteoblastogenesis and osteoclastogenesis and reduce osteoblast lifespan of [9-11].”
Differentiation stage alters matrix control of stem cells
Hsiong, S. X., Carampin, P., Kong, H., Lee, K. Y., & Mooney, D. J. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31521 · Cited by 97
Microcalcifications in breast cancer: Lessons from physiological mineralization
Cox, R. F., & Morgan, M. P. (2013) · Bone · doi:10.1016/j.bone.2013.01.013 · Cited by 97
“It has been suggested that the effect of dexamethasone is species-specific, as in themouse pre-osteoblast MC3T3-E1 cell line addition of dexamethasone decreases mineralization compared to the osteogenic cocktail alone [36].”
ResultVitamin D endocrinology of bone mineralization
van Driel, M., & van Leeuwen, J. P. T. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.008 · Cited by 95
Hsiong, S. X., Boontheekul, T., Huebsch, N., & Mooney, D. J. (2008) · Tissue Engineering Part A · doi:10.1089/ten.tea.2007.0411 · Cited by 94
Boguslawski, G., Hale, L. V., Yu, X., Miles, R. R., Onyia, J. E., Santerre, R. F., & Chandrasekhar, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.999 · Cited by 94
Vitamin D endocrine system and osteoblasts.
van Driel, M., & van Leeuwen, J. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2013.227 · Cited by 81
En-Nosse, M., Hartmann, S., Trinkaus, K., Alt, V., Stigler, B., Heiß, C., Kilián, O., Schnettler, R., & Lips, K. S. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0871-1 · Cited by 88
“…using RT-PCR in native MC3T3-E1 and MC3T3-E1 cells incubated with DMEM containing FCS, dexamethasone, ascorbic acid-2 phosphate, and β-glycerolphosphate, a formulation used for osteogenetic differentiation of cells from human reaming debris into osteoblasts (Wenisch et al. 2005; Lian et al. 1997).”
BackgroundMethodSustained In Vitro Expansion of Bone Progenitors Is Cell Density Dependent
Purpura, K. A., Aubin, J. E., & Zandstra, P. W. (2004) · Stem Cells · doi:10.1634/stemcells.22-1-39 · Cited by 85
Regulated Expression of the Bone-Specific Osteocalcin Gene by Vitamins and Hormones
Lian, J. B., Stein, G. S., Stein, J. L., & van Wijnen, A. J. (1998) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60941-3 · Cited by 84
Self-citationRussell, J., Ashok, S., & Koszewski, N. J. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.11.1828 · Cited by 83
Cortisol regulates the expression of Notch in osteoblasts
Pereira, R. M. R., Delany, A. M., Durant, D., & CANALIS, E. M. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10125 · Cited by 80
Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts
van Driel, M., & van Leeuwen, J. P. T. M. (2023) · Nutrients · doi:10.3390/nu15030480 · Cited by 82
Greek Plant Extracts Exhibit Selective Estrogen Receptor Modulator (SERM)-like Properties
Kassi, E. N., Papoutsi, Z., Fokialakis, N., Messari, I., Mitakou, S., & Moutsatsou, P. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0400765 · Cited by 79
Cox, R. F., Jenkinson, A., Pohl, K., O’Brien, F. J., & Morgan, M. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041679 · Cited by 73
1,25-(OH)2D3Down-Regulates Expression ofPhex, a Marker of the Mature Osteoblast1
Ecarot, B., & Desbarats, M. (1999) · Endocrinology · doi:10.1210/endo.140.3.6593 · Cited by 71
Eyckmans, J., Roberts, S. J., Bolander, J., Schrooten, J., Chen, C. S., & Luyten, F. P. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.011 · Cited by 68
Sims, N. A., White, C., Sunn, K. L., Thomas, G. P., Drummond, M. L., Morrison, N. A., Eisman, J. A., & Gardiner, E. M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.11.0008 · Cited by 68
“Supporting this concept, recent studies have verified such a species-related difference, showing the mouse osteocalcin gene to be down-regulated rather than induced by 1,25-(OH)2D3 in vivo and in vitro (38, 39).”
Siddappa, R., Fernandes, H., Liu, J., van Blitterswijk, C., & de Boer, J. (2007) · Current Stem Cell Research & Therapy · doi:10.2174/157488807781696267 · Cited by 66
The role of sirtuin 1 in osteoblastic differentiation in human periodontal ligament cells
Lee, Y. ‐., Shin, S., Shin, K. ‐., Lee, Y., Park, B., & Kim, E. ‐. (2011) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2011.01394.x · Cited by 64
Bellows, C. G., Ciaccia, A., & Heersche, J. N. M. (1998) · Bone · doi:10.1016/s8756-3282(98)00084-2 · Cited by 64
Vitamin D receptor and retinoid X receptor interactions in motion
Bársony, J., & Prüfer, K. (2002) · Vitamins and hormones · doi:10.1016/s0083-6729(02)65071-x · Cited by 63
Osteocalcin Production in Primary Osteoblast Cultures Derived from Normal and Hyp Mice
Carpenter, T. O., Moltz, K. C., Ellis, B. K., Andreoli, M., McCarthy, T. L., Bryan, D., & Gundberg, C. M. (1998) · Endocrinology · doi:10.1210/endo.139.1.5677 · Cited by 62
Maehata, Y., Takamizawa, S., Ozawa, S., Kato, Y., Sato, S., Kubota, E., & Hata, R. (2005) · Matrix Biology · doi:10.1016/j.matbio.2005.09.001 · Cited by 62
Mikami, Y., Lee, M., Irie, S., & Honda, M. J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22392 · Cited by 60
“Dexamethasone (Dex) is a synthetic glucocorticoid (GC) that is frequently used in the treatment of severe inflammatory diseases (Lian et al., 1997).”
BackgroundThe local production of 1,25(OH)2D3 promotes osteoblast and osteocyte maturation
Turner, A. G., Hanrath, M. A., Morris, H. A., Atkins, G. J., & Anderson, P. H. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.10.003 · Cited by 57
Liu, B.-Y., Guo, J., Lanske, B., Pajevic, P. D., Kronenberg, H. M., & Bringhurst, F. R. (1998) · Endocrinology · doi:10.1210/endo.139.4.5895 · Cited by 59
Luppen, C. A., Leclerc, N., Noh, T., Barski, A., Khokhar, A., Boskey, A. L., Smith, E., & Frenkel, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306730200 · Cited by 58
Self-citationMikami, Y., Omoteyama, K., Kato, S., & Takagi, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.192 · Cited by 57
Azuma, H., Kido, J., Ikedo, D., Kataoka, M., & Nagata, T. (2004) · Journal of Periodontology · doi:10.1902/jop.2004.75.7.974 · Cited by 57
1,25-Dihydroxyvitamin D and Klotho
Haussler, M. R., Whitfield, G. K., Haussler, C. A., Sabir, M. S., Khan, Z., Sandoval, R., & Jurutka, P. W. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2015.11.005 · Cited by 54
Leclerc, N., Noh, T., Khokhar, A., Smith, E., & Frenkel, B. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20872 · Cited by 54
Self-citation24,25-Dihydroxyvitamin D3 and bone metabolism
van Leeuwen, J. P. T. M., van den Bemd, G.-J. C. M., van Driel, M., Buurman, C. J., & Pols, H. A. P. (2001) · Steroids · doi:10.1016/s0039-128x(00)00155-0 · Cited by 53
Parathyroid Hormone Induction of the Osteocalcin Gene
Jiang, D., Franceschi, R. T., Boules, H., & Xiao, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311547200 · Cited by 52
Hulley, P. A., Conradie, M., Langeveldt, C., & Hough, F. S. (2002) · Bone · doi:10.1016/s8756-3282(02)00807-4 · Cited by 52
Hong, D., Chen, H.-X., Yu, H., Wang, C., Deng, H., Lian, Q., & Ge, R. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1434-8 · Cited by 51
“In accordance with the previous data [13–16], we demonstrated that a high dose of DEX inhibited osteoblast differentiation and cell proliferation but promoted apoptosis in MC3T3-E1 cells on day 7.”
Shui, C., & Scutt, A. M. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10157 · Cited by 48
“Unfortunately, the effects of glucocorticoids on VDR levels are not clear, there have been reports of glucocorticoids apparently increasing (Maenpaa et al., 1991), decreasing (Godschalk et al., 1992), or have no effect (Mahonen and Maenpaa, 1994) on VDR levels in osteoblastic cells.”
BackgroundEnhancement of osteogenic gene expression for the differentiation of human periosteal derived cells
Roberts, S. J., Chen, Y., Moesen, M., Schrooten, J., & Luyten, F. P. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.04.003 · Cited by 46
“For example Dex has been shown to block osteogenic differentiation of murine osteoprogenitor cells with VitD3 shown to down regulate osteocalcin (OCN) within the same cell type (Lian et al., 1997).”
BackgroundGlendenning, P., Ratajczak, T., Dick, I. M., & Prince, R. L. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1908 · Cited by 46
Clinical and Basic Aspects of Glucocorticoid Action in Bone
Kream, B. E., Graves, L., & Lukert, B. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00061-6 · Cited by 47
Involvement of SMRT Corepressor in Transcriptional Repression by the Vitamin D Receptor
Kim, D. Y., Son, Y. L., & Lee, Y. C. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0426 · Cited by 44
“tamin D (D3) (13, 14) and glucocorticoids (15, 16), and a num-”
Merle, B., Bouet, G., Rousseau, J., Bertholon, C., & Garnero, P. (2013) · Cell Biology International · doi:10.1002/cbin.10219 · Cited by 43
“Indeed, 1.25 (OH)2D3 did not influence differentiation of mouse osteoblastic cells assessed by the expression of ALP, osteocalcin and collagen I mRNA, but stimulated the differentiation of human osteoblasts (Lian et al., 1997; Song et al., 2011).”
BackgroundInfluentialStaal, A., Geertsma-Kleinekoort, W. M. C., van den Bemd, G. J. C. M., Buurman, C. J., Birkenhäger, J. C., Pols, H. A. P., & van Leeuwen, J. P. T. M. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.1.36 · Cited by 43
“(33,34) Previously, it was shown that the hypophosphatemic Hyp mice have increased serum osteocalcin levels, which are reduced by 1,25(OH)2D3 treatment.”
BackgroundLuppen, C. A., Luppen, C. A., Chandler, R. L., Noh, T., Mortlock, D. P., & Frenkel, B. (2008) · Growth Factors · doi:10.1080/08977190802277880 · Cited by 42
“2003a) and mineralization in MC3T3-E1 osteoblast cultures (Lian et al. 1997; Luppen et al. 2003b; Smith et al. 1999), and that rhBMP-2 rescues mineralization in this model system (Luppen et al.”
BackgroundSelf-citationAslam, F., McCabe, L. R., Frenkel, B., van Wijnen, A. J., Stein, G. S., Lian, J. B., & Stein, J. L. (1999) · Endocrinology · doi:10.1210/endo.140.1.6429 · Cited by 43
Self-citationFratzl‐Zelman, N., Glantschnig, H., Rumpler, M., Nader, A., Ellinger, A., & Varga, F. (2003) · Cell Biology International · doi:10.1016/s1065-6995(03)00037-4 · Cited by 42
“Consistent with earlier reports (Lian et al., 1997; Zhang et al., 1997), 1,25-(OH)2D3 did not stimulate Osc expression in mice (Fig.”
BackgroundResultInfluentialWhitfield, G., Jurutka, P., Haussler, C., Hsieh, J.-C., Barthel, T., Jacobs, E. T., Dominguez, C. E., Thatcher, M. L., & Haussler, M. (2005) · Elsevier eBooks · doi:10.1016/b978-012252687-9/50016-4 · Cited by 48
Sordi, M. B., Curtarelli, R. B., Silva, I. T., Fongaro, G., Benfatti, C. A. M., Magini, R. D. S., & da Cruz, A. C. C. (2021) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-020-06475-6 · Cited by 40
“[14] that found inhibition of osteoblastic differentiation of MC3T3E1 by the chronic use of DEX through the downregulation of osteocalcin gene expression.”
BackgroundBeier, E. E., Sheu, T., Resseguie, E. A., Takahata, M., Awad, H. A., Cory‐Slechta, D. A., & Puzas, J. E. (2017) · Bone Research · doi:10.1038/boneres.2017.13 · Cited by 40
Lee, Y.-S., Chen, X., & Anderson, J. J. B. (2001) · Nutrition Research · doi:10.1016/s0271-5317(01)00340-2 · Cited by 39
Lian, J. B., Stein, J. L., Stein, G. S., Montecino, M. A., van Wijnen, A. J., Javed, A., & Gutiérrez, S. (2001) · Steroids · doi:10.1016/s0039-128x(00)00160-4 · Cited by 39
Self-citationRimando, M. G., Wu, H.-H., Liu, Y.-A., Lee, C., Kuo, S.-W., Lo, Y.-P., Tseng, K., Liu, Y., & Lee, O. K. (2016) · Scientific Reports · doi:10.1038/srep37371 · Cited by 38
Bellows, C. G., Heersche, J. N. M., & Aubin, J. E. (1999) · Calcified Tissue International · doi:10.1007/s002239900658 · Cited by 37
“One possibility is that the differences reflect species differences between the rat and mouse since these two species also differ greatly in their response to glucocorticoid hormones [33–35].”
BackgroundNishimura, N., Nishimura, H., Ito, T., Miyata, C., Izumi, K., Fujimaki, H., & Matsumura, F. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.01.025 · Cited by 37
Development of a Three-Dimensional Bone-Like Construct in a Soft Self-Assembling Peptide Matrix
Marí‐Buyé, N., Luque, T., Navajas, D., & Semino, C. E. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0077 · Cited by 35
Full-mouth rehabilitation using dental implants in a patient with scleroderma.
Zigdon, H., Gutmacher, Z., Teich, S., & Levin, L. (2011) · PubMed · Cited by 30
Im, H., Craig, T. A., Pittelkow, M. R., & Kumar, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205450 · Cited by 27
“The rat and human osteocalcin VDREs mediate positive regulation, but when two bases are substituted in the 5' steroid half element, repression of the promoter activity was observed upon treatment with vitamin D3 (Lian et al., 1997).”
BackgroundHaussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J., & Jurutka, P. W. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10008-3 · Cited by 26
Biocompatibility of poly(etherurethane urea) containing dehydroepiandrosterone
Collier, T. O., Tan, J., Shive, M. S., Hasan, S. M., Hiltner, A., & Anderson, J. (1998) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199808)41:2 · Cited by 11
Lie, K. K., & Moren, M. (2011) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2011.10.023 · Cited by 25
Hormonal Regulation of the Osteoblastic Phenotype Expression in Neonatal Murine Calvarial Cells
Chen, T. L., & Fry, D. (1999) · Calcified Tissue International · doi:10.1007/s002239900624 · Cited by 25
Species-Divergent Regulation of Human and Mouse Osteocalcin Genes by Calciotropic Hormones
Thomas, G. P., Bourne, A., Eisman, J. A., & Gardiner, E. M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4912 · Cited by 24
Secreted factors from adipose tissue increase adipogenic differentiation of mesenchymal stem cells
Wu, L., Wang, T., Ge, Y., Cai, X., Wang, J., & Lin, Y. (2012) · Cell Proliferation · doi:10.1111/j.1365-2184.2012.00823.x · Cited by 23
Li, C., Wang, B., Liu, X., Pan, Z., Liu, C., Ma, H., Liu, X., Liu, L., & Jiang, C. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1609007 · Cited by 22
“Liano and co-workers indicated that exposure of MC3T3-E1 cells to Dex, initiated during the proliferation period, blocked osteoblast differentiation, had a negative effect on ALP activity, which is consistent with our results [36].”
ResultPurpura, K. A., Zandstra, P. W., & Aubin, J. E. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10596 · Cited by 20
“Immunolabeling of RC cultures was done as described previously [Liu et al., 1994].”
MethodLiu, B.-Y. (1998) · Endocrinology · doi:10.1210/en.139.4.1952 · Cited by 20
Atkins, G. J., Findlay, D. M., Anderson, P., & Morris, H. A. (2005) · Elsevier eBooks · doi:10.1016/b978-012252687-9/50044-9 · Cited by 19
Changes in Phenotypic Expression of Osteoblasts after X Irradiation
Matsumura, S., Hiranuma, H., Deguchi, A., Maeda, T., Jikko, A., & Fuchihata, H. (1998) · Radiation Research · doi:10.2307/3579786 · Cited by 19
Siggelkow, H., Schenck, M., Rohde, M., Viereck, V., Tauber, S. C., Atkinson, M. J., & Hüfner, M. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10122 · Cited by 18
Lian, J. B., & Stein, G. S. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50003-9 · Cited by 18
Self-citationEffects of Extracellular Osteoanabolic Agents on the Endogenous Response of Osteoblastic Cells
Alloisio, G., Ciaccio, C., Fasciglione, G. F., Tarantino, U., Marini, S., Coletta, M., & Gioia, M. (2021) · Cells · doi:10.3390/cells10092383 · Cited by 20
Liu, X., Liu, Y., Mathers, J., Cameron, M. S., Levinger, I., Yeap, B. B., Lewis, J. R., Brock, K. E., & Brennan‐Speranza, T. C. (2020) · Archives of Osteoporosis · doi:10.1007/s11657-020-00812-6 · Cited by 18
Oscillatory Perfusion Culture of CaP-Based Tissue Engineering Bone with and without Dexamethasone
Du, D., Furukawa, K. S., & Ushida, T. (2008) · Annals of Biomedical Engineering · doi:10.1007/s10439-008-9586-9 · Cited by 17
Hsieh, J., Whitfield, G. K., Jurutka, P. W., Haussler, C. A., Thatcher, M. L., Thompson, P. D., Dang, H. T. L., Galligan, M. A., Oza, A. K., & Haussler, M. R. (2003) · Endocrinology · doi:10.1210/en.2003-0635 · Cited by 17
Vitamin K Dependent Proteins of Bone and Cartilage
Gundberg, C. M., & Nishimoto, S. K. (2006) · Elsevier eBooks · doi:10.1016/b9-78-012088-5/62650-0042 · Cited by 17
Metadata
- Authors
- Lian, J. B., Shalhoub, V., Aslam, F., Frenkel, B., Green, J., Hamrah, M., Stein, G. S., & Stein, J. L.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1997-05-01
- Volume
- 138
- Issue
- 5
- Pages
- 2117-2127
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2169357450
- Cited by
- 154
- References
- 56
- Citations by year
- 2023: 3 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 2 · 2013: 6 · 2012: 10
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Institutes of Health (5r01ar033920-12, 5r01dk046721-03)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-46721)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR33920)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- glucocorticoids, 1,25-dihydroxyvitamin D3, dexamethasone, osteogenic differentiation, MC3T3-E1 cells, osteocalcin gene expression, vitamin D response element, osteoblast maturation, bone mineralization, glucocorticoid receptor, 1,25-dihydroxyvitamin D3 receptor, osteopontin, collagen, histone H2B
- MeSH terms
- Animals, Base Sequence, Calcitriol, Cell Differentiation, Cell Line, Dexamethasone, Glucocorticoids, Histones, Osteoblasts, Promoter Regions, Genetic, RNA, Messenger, Time Factors, Transfection, Osteocalcin, Gene Expression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review